½üÈÕ£¬Ð±¦GGҽѧԺÑî½£¸±½ÌÊÚÍŶÓ/ÉϺ£ËÄÖðÒ»Ò½Ôº£¨Ð±¦GG´ÓÊôËÄÖðÒ»Ò½Ôº£©ÔÚ·Ö×ÓÓ°ÏñÁìÓòµÄTOPÆÚ¿¯¡¶European Journal of Nuclear Medicine and Molecular Imaging¡·£¨ÖпÆÔº1ÇøIF=9.1£©Éϰ䷢ÃûΪ¡°Near-infrared II theranostic agents for the diagnosis and treatment of Alzheimer¡¯s disease¡±£¨½üºì±íII·Ö±æ×ÓÓÃÓÚ°¢¶û´Äº£Ä¬Ö¢Õï¶ÏºÍÒ½ÖεÄ×êÑнøÕ¹£©µÄ×ÛÊöÂÛÎÄ¡£½üºì±íIIÇøÓ«¹â³ÉÏñÒòÆä¹ÖÒìµÄÓÅÊÆ£¬ÔÚADÕï¶ÏºÍÒ½Öη½ÃæÓµÓо޴óµÄDZÁ¦¡£»ùÓÚ½üºì±í¢òÇøÓ«¹â³ÉÏñ£¬×÷Õß¶Ôµ±Ç°ÓÃÓÚADµÄÕï¶ÏµÄ½üºì±í¢ò·Ö±æ×Ó̽ÕëÒÔ¼°»ùÓÚ½üºì±í¢ò·Ö±æ×ÓÓÃÓÚADµÄ¹âÈÈÒ½Öμ°¹â¶¯Á¦Ò½ÖνøÐÐÁËϵͳÐÔ¸ÅÊö£¬Ì½ÇóÁËÔÚADÕï¶ÏÓëÒ½Öιý³ÌÖÐÓöµ½µÄÎÊÌâÓëÌôÕ½£¬²¢¶Ô½«À´ADµÄÕï¶ÏÓëÒ½ÖÎ×ö³öÁËÕ°Íû¡£

ÆÚ¿¯¼ò½é

¡¶European Journal Of Nuclear Medicine And Molecular Imaging¡·(¡¶Å·ÖÞºËҽѧÓë·Ö×Ó³ÉÏñÔÓÖ¾¡·£©ÊÇÒ»±¾ÓÉSPRINGER³ö°æµÄҽѧ£ºËҽѧѧÊõ¿¯Î¸Ã¿¯Êǹú¼ÊÒ»Á÷ÆÚ¿¯£¬ÖØÒª¿¯ÔØÒ½Ñ§£ºËҽѧÓйØÁìÓò×êÑгɾÍÓëʵ¼Ê£¬Ö¼ÔÚ´òÔìÒ»ÖÖѧÊõˮƽ¸ß¡¢¿É¶ÁÐÔÇ¿¡¢ÓµÓÐÈ«ÇòÓ°ÏìÁ¦µÄѧÊõÆÚ¿¯¡£±¾¿¯ÒÑÈëÑ¡SCI¡¢SCIEÆðÔ´ÆÚ¿¯¡£¸Ã¿¯´´¿¯ÓÚ1976Ä꣬³ö°æÖÜÆÚMonthly¡£2022Äê°ä²¼µÄÓ°ÏìÒò×ÓΪ9.1¡£
°¢¶û×Ⱥ£Ä¬²¡¿ÆÆÕ
°¢¶û´Äº£Ä¬²¡£¨Alzheimer's disease, AD£©£¬ÊÇÒ»ÖÖÑϳÁµÄÉñ¾ÍËÐÐÐÔ¼²²¡£¬¼«´óµØÓ°ÏìÓ×ÎÒ¡¢¼ÒÍ¥ÉõÖÁÉç»áµÄ·¢Õ¹¡£¶ÔÓÚÀÏÄêÈËÀ´Ëµ£¬ADÒѾ³ÉΪ¼ÌÐÄÔಡ¡¢°©Ö¢¡¢ÖзçÖ®ºóµÄµÚËÄ´óɱÊÖ¡£ÎÒ¹úAD»¼ÕßÈËÊýÒѾÓÊÀ½çµÚÒ»£¬Í¬Ê±Ò²ÊÇÈ«ÇòÔö¿ì×î¿ìµÄ¹ú¶ÈÖ®Ò»¡£ÁîÈËÒź¶µÄÊÇ£¬ÓÉÓÚ²¡Òò¸´ÔÓ£¬Æù½ñΪֹ»¹Ã»ÓÐÆëÈ«×èÖ¹»òÑÓ»º¼²²¡½øÕ¹µÄ²½Öè¡£½üÄêÀ´£¬Éñ¾Ó°ÏñѧµÄ·¢Õ¹ÓÈÆäÊÇÐÂÐÍ·Ö×Ó̽ÕëµÄ·¢ÏÖ£¬ÎªADµÄÔçÆÚÕï¶ÏºÍÒ½ÖÎÌṩÁ˹¤¾ß¡£